Tags: Chemical Compound, Chemical Substance.

Mitemcinal (GM-611 or 3′-N-dimethyl-11-deoxy-3′-N-isopropyl-12-O-methyl-11-oxo-89-didehydroerythromycin) is a motilin agonist derived from the macrolide antibiotic erythromycin. It was discovered in the labs of Chugai Pharma. Mitemcinal is orally administered and it is believed to have strong promotility (or prokinetic) effects. Promotility drugs relieve symptoms of reflux by speeding the clearance of acid from the oesophagus and stomach.

Mitemcinal.png
FDA UNII code
6X5NRJ664L
IUPAC name
(1R2R3S4S5R8R9R11S)-8-ethyl-4-[(2R4R5S6S)-5-hydroxy-4-methoxy-46-dimethyloxan-2-yl]oxy-2-[(2S3R4S6R)-3-hydroxy-6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-yl]oxy-9-methoxy-13591113-hexamethyl-715-dioxabicyclo[10.2.1]pentadec-12-ene-610-dione

Loading...

This page contains content from the copyrighted Wikipedia article "Mitemcinal"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.